Carregant...
HPV16E6 antibodies are sensitive for HPV-driven oropharyngeal cancer and associated with recurrence
BACKGROUND: HPV16E6 antibodies may be an early marker of HPV-driven oropharyngeal cancer (HPV-OPC) diagnosis and recurrence. METHODS: We identified 161 incident OPCs diagnosed at the University of Pittsburgh (2003–2013) with pre-treatment serum; 112 had pre-existing clinical HPV testing with p16 imm...
Guardat en:
| Publicat a: | Cancer |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743332/ https://ncbi.nlm.nih.gov/pubmed/28950407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30966 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|